Here we have investigated the effects of MEK5/ERK5 signalling on the DNA replication initiation machinery in prostate carcinogenesis to determine how this might influence origin licensing and cell cycle kinetics of this tumour type in vivo. This evidence concerns the gene MAP2K5 and prostatitis.